Parecoxib Sodium Lyophilized Powder for injection, will be used for short-term treatment of acute pain and post-operative pain in adult patients. It is the first parenteral selective COX-2 inhibitor available for clinical use in pain management.

Gufic Biosciences is a pharmaceutical company engaged in research and development, manufacturing, marketing, distribution, and sale of pharmaceutical and herbal products. Its products include a wide range of Active Pharmaceutical Ingredients (APIs). Gufic is a leading manufacturer of Lyophilized injections, boasting a fully automated lyophilization plant.

Net profit of Gufic Biosciences declined 2.04% to Rs 20.62 crore while net sales rose 17.99% to Rs 195.02 crore in Q1 June 2023 over Q1 June 2022.